APP and Alzheimer disease: Aβ42 and Aβ40 forms – named based on the number of amino acids composing them following APP cleavage - are predominantly implicated in the pathogenesis of AD due to their heightened tendency to aggregate in the extracellular matrix (Hefter et al., 2020).